YEKATERINBURG. Bayer, the German corporation, and Medsintez, the Novouralsk plant, have agreed on joint drug manufacturing.

As the Governor’s Department of Information Policy shared with IPA, the corresponding agreement was signed, in the presence of the Governor YevgenyKuyvashev, by Alexander Petrov, Medsintez Chairman of the Board of Directors, and Dr. Victor Gaisler, the Bayer Helskea Global representative, Head of Bayer Helskea Pharmaceuticals in Russia,

The first medicine produced jointly will be the Avelox antibiotic, which will now be manufactured at the Sverdlovsk enterprise. The Medsintez plant has undergone a series of audits for compliance with the German corporation's quality standards. Under the partnership agreement, Bayer will provide Medsintez with production technologies, raw materials and supplies.

Test lots of Aveloks will be produced as soon as this year. The launch of the commercial production of the drug is scheduled for 2014. The antibiotic manufactured in Novouralsk will be packed in plastic containers to facilitate its  delivery to hospitals as well as putting in and use of IVs.

EvgenyKuyvashev expressed confidence that the signed agreement would not only raise the production of unique medicines in the Sverdlovsk Region to a new level but also provide all Ural residents with the opportunity to buy high-quality and affordable medicines.